PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
15-May-2024 Cantourage Group SE records strong growth in revenue and EBITDA in the break-even range in 2023. Strong growth since the partial legalisation of cannabis came into force. Cantourage Group SE
15-May-2024 Ad-hoc: Cantourage Group SE records strong growth in 2024 since the partial legalisation of cannabis came into force Cantourage Group SE
15-May-2024 Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy Dermapharm Holding SE
15-May-2024 MS Pharma becomes Partner for the Commercialization of FYB203, Formycon’s Biosimilar Candidate to Eylea® (Aflibercept), in the MENA Region Formycon AG
14-May-2024 SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from syringes SCHOTT Pharma AG & Co. KGaA
14-May-2024 SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma see FY 25 impacted by slower growth from syringes SCHOTT Pharma AG & Co. KGaA
14-May-2024 InsightRX Continues Momentum in Precision Dosing with Client Growth, New Scientific Breakthroughs InsightRX
14-May-2024 DEFENCE THERAPEUTICS STRENGTHENS AND EXPANDS GLOBAL PATENT PROTECTION ON KEY TECHNOLOGIES Defence Therapeutics Inc.
14-May-2024 Eckert & Ziegler with significant increase in sales (+17%) and adjusted EBIT (+41%) in Q1. Forecast 2024 confirmed. Eckert & Ziegler SE
14-May-2024 PharmaSGP continues dynamic business development with significant revenues growth in Q1 2024 PharmaSGP Holding SE
14-May-2024 Q1 2024 Qualitative Update: Performance In Line with Expectations for Full-Year 2024 Lonza Group AG
14-May-2024 DocMorris AG: DocMorris announces results of Tender Offer DocMorris AG
14-May-2024 Biophytis announces the design of its phase 2 OBA clinical study in obesity Biophytis
13-May-2024 Newron reports compelling additional data documenting the efficacy of evenamide in pivotal study 008A in poorly responding schizophrenia patients Newron Pharmaceuticals S.p.A.
10-May-2024 MODERNA WELCOMES THE SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE TO THE MODERNA INNOVATION AND TECHNOLOGY CENTRE IN OXFORDSHIRE Moderna
10-May-2024 Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH) MPH Health Care AG
09-May-2024 Takeda Pharmaceutical Company Limited: Takeda Announces Enterprise-wide Program to Support Growth and Deliver Core Operating Profit Margin Improvement Takeda Pharmaceutical Company Limited
08-May-2024 Drägerwerk AG & Co. KGaA: Dräger makes sustainability and quality an Executive Board responsibility Drägerwerk AG & Co. KGaA
08-May-2024 Drägerwerk AG & Co. KGaA: Dräger annual shareholders’ meeting approves significant dividend increase Drägerwerk AG & Co. KGaA
08-May-2024 Lonza Announces Results of the 2024 Annual General Meeting – All Motions Proposed by Board of Directors Approved Lonza Group AG